• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像与放射性核素闪烁扫描术在骨转移瘤筛查中的比较

Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.

作者信息

Traill Z C, Talbot D, Golding S, Gleeson F V

机构信息

Department of Radiology, Churchill Hospital, Headington, Oxford, UK.

出版信息

Clin Radiol. 1999 Jul;54(7):448-51. doi: 10.1016/s0009-9260(99)90830-9.

DOI:10.1016/s0009-9260(99)90830-9
PMID:10437696
Abstract

AIM

To determine the frequency of isolated, asymptomatic metastases of the peripheral skeleton in patients with breast and prostate cancer.

METHODS

A retrospective review was performed of staging skeletal scintigrams. Patients with hot spots in the peripheral skeleton in the absence of convincing evidence of metastatic disease in the axial skeleton were followed-up to determine the nature of the peripheral lesion(s) based on other imaging modalities, serial imaging or biopsy, and to determine if the lesion(s) had been symptomatic at the time of the scintigram.

SUBJECTS

200 patients with histologically proven carcinomas of the breast or prostate.

RESULTS

Four patients (2%) had isolated metastatic involvement of the peripheral skeleton, and would, therefore, have been wrongly staged by a magnetic resonance 'marrow screen' of the axial skeleton. However, in three of these patients the lesions were painful, prompting diagnostic plain radiographs independent of the scintigraphic findings. Twelve patients (6%) had isolated scintigraphic abnormalities of the peripheral skeleton suggestive of metastatic disease but which on further investigation were shown to be benign lesions.

CONCLUSION

A limited magnetic resonance (MR) 'marrow screen' confined to the axial skeleton would not result in any significant loss of accuracy in staging patients with breast and prostate carcinoma compared with skeletal scintigraphy. Given the proven increased sensitivity of MR over skeletal scintigraphy in the detection of bone metastases, and the additional information MR provides, it is likely to provide a more accurate basis for management.

摘要

目的

确定乳腺癌和前列腺癌患者外周骨骼孤立性无症状转移的发生率。

方法

对分期骨骼闪烁扫描进行回顾性分析。对轴向骨骼无确凿转移疾病证据但外周骨骼有热点的患者进行随访,以根据其他成像方式、系列成像或活检确定外周病变的性质,并确定在闪烁扫描时病变是否有症状。

研究对象

200例经组织学证实为乳腺癌或前列腺癌的患者。

结果

4例患者(2%)有外周骨骼孤立性转移受累,因此,通过轴向骨骼的磁共振“骨髓筛查”会导致分期错误。然而,其中3例患者的病变有疼痛症状,促使进行独立于闪烁扫描结果的诊断性X线平片检查。12例患者(6%)有外周骨骼孤立性闪烁扫描异常,提示转移疾病,但进一步检查显示为良性病变。

结论

与骨骼闪烁扫描相比,仅局限于轴向骨骼的有限磁共振(MR)“骨髓筛查”在乳腺癌和前列腺癌患者分期中不会导致准确性有任何显著损失。鉴于已证实MR在检测骨转移方面比骨骼闪烁扫描具有更高的敏感性,以及MR提供的额外信息,它可能为治疗提供更准确的依据。

相似文献

1
Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.磁共振成像与放射性核素闪烁扫描术在骨转移瘤筛查中的比较
Clin Radiol. 1999 Jul;54(7):448-51. doi: 10.1016/s0009-9260(99)90830-9.
2
Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study.磁共振成像和闪烁扫描术对轴向骨骼转移性乳腺癌患者的诊断价值:一项对比研究
Med Oncol. 2008;25(3):257-63. doi: 10.1007/s12032-007-9027-x. Epub 2007 Nov 27.
3
Comparative detectability of bone metastases and impact on therapy of magnetic resonance imaging and bone scintigraphy in patients with breast cancer.乳腺癌患者骨转移的磁共振成像与骨闪烁显像的比较可检测性及其对治疗的影响
Eur J Radiol. 2001 Oct;40(1):16-23. doi: 10.1016/s0720-048x(01)00313-8.
4
Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumors of the axial skeleton.磁共振成像与骨髓闪烁显像在轴向骨骼转移性实体瘤患者中的比较诊断价值及治疗相关性
Eur J Radiol. 2002 Sep;43(3):256-61. doi: 10.1016/s0720-048x(01)00477-6.
5
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
6
Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma.全身磁共振弥散加权成像与骨扫描在前列腺癌或乳腺癌患者骨转移检测中的比较。
Skeletal Radiol. 2010 Apr;39(4):333-43. doi: 10.1007/s00256-009-0789-4.
7
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.高危前列腺癌患者轴向骨骼的磁共振成像用于检测骨转移:诊断及成本效益分析以及与当前检测策略的比较
J Clin Oncol. 2007 Aug 1;25(22):3281-7. doi: 10.1200/JCO.2006.09.2940.
8
[Metastatic bone disease. Strategies for imaging].[转移性骨病。影像学策略]
Minerva Med. 2003 Apr;94(2):77-90.
9
The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.骨闪烁显像、骨髓闪烁显像及快速自旋回波磁共振成像在恶性实体瘤患者分期中的价值:一项前瞻性研究。
Eur J Nucl Med. 1993 Nov;20(11):1063-9. doi: 10.1007/BF00173484.
10
Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)与骨闪烁显像在乳腺癌骨转移检测中的比较
Acta Radiol. 2011 Nov 1;52(9):1009-14. doi: 10.1258/ar.2011.100507. Epub 2011 Oct 3.

引用本文的文献

1
Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer.多参数全身磁共振成像:转移性前列腺癌治疗的变革者
Cancers (Basel). 2024 Jul 13;16(14):2531. doi: 10.3390/cancers16142531.
2
Imaging for Plasma Cell Dyscrasias: What, When, and How?浆细胞异常增殖性疾病的影像学检查:检查什么、何时检查以及如何检查?
Front Oncol. 2022 Mar 24;12:825394. doi: 10.3389/fonc.2022.825394. eCollection 2022.
3
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.骨转移是可测量的:全身磁共振成像和正电子发射断层扫描的作用。
Front Oncol. 2021 Nov 19;11:772530. doi: 10.3389/fonc.2021.772530. eCollection 2021.
4
Comparison of whole-body bone scintigraphy with axial skeleton magnetic resonance imaging in the skeletal evaluation of carcinoma prostate.全身骨闪烁显像与轴位骨骼磁共振成像在前列腺癌骨骼评估中的比较。
Indian J Urol. 2021 Jan-Mar;37(1):72-78. doi: 10.4103/iju.IJU_238_20. Epub 2021 Jan 1.
5
Care of cancer patients with liver and bone metastases - the place of pharmaceutical care in a balanced plan, focused on the patient's needs and goals.伴有肝转移和骨转移的癌症患者的护理——药学服务在以患者需求和目标为重点的综合方案中的作用。
Arch Med Sci. 2017 Oct;13(6):1483-1492. doi: 10.5114/aoms.2016.60509. Epub 2016 Jun 13.
6
Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis.胆碱-PET/CT、MRI、SPECT和骨闪烁显像在前列腺癌患者骨转移诊断中的比较:一项荟萃分析。
Skeletal Radiol. 2014 Nov;43(11):1503-13. doi: 10.1007/s00256-014-1903-9. Epub 2014 May 20.
7
Bone scan is of doubtful value as a first staging test in the primary presentation of prostate cancer.在前列腺癌的初次表现中,骨扫描作为首要分期检查的价值存疑。
ISRN Oncol. 2012;2012:585017. doi: 10.5402/2012/585017. Epub 2012 Nov 5.
8
Musculoskeletal disorders in the elderly.老年人的肌肉骨骼疾病
J Clin Imaging Sci. 2012;2:39. doi: 10.4103/2156-7514.99151. Epub 2012 Jul 28.
9
Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?前列腺癌骨转移的现代检测:骨扫描时代是否已终结?
Adv Urol. 2012;2012:893193. doi: 10.1155/2012/893193. Epub 2011 Oct 16.
10
Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa).全身磁共振成像(WB-MRI)与轴向骨骼磁共振成像(AS-MRI)在前列腺癌(PCa)中检测和测量骨转移的比较。
Eur Radiol. 2010 Dec;20(12):2973-82. doi: 10.1007/s00330-010-1879-3. Epub 2010 Jul 27.